Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EnSite to enter US trial for left atrial use:

This article was originally published in Clinica

Executive Summary

Endocardial Solutions is to begin a US clinical trial to assess its EnSite 3000 three-dimensional mapping system as a means of diagnosing arrhythmias, including atrial fibrillation, in the left atrium of the heart. The trial is expected to start in the second quarter of 2001 and will include up to eight institutions in the US and Canada, says the St Paul, Minnesota company. The product was cleared by the FDA for use in the right atrium in 1999. It is also available in Europe for right atrial and left ventricular use.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069784

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel